pacDNA
PrivateLast Round
Grant
Jan 17, 2025
Total Funding Raised
$2.99M
Company Overview
pacDNA is a biotechnology company that develops oligonucleotide therapeutics for the treatment of cancer and rare genetic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
pacDNA Comparables
Compare pacDNA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Entos Pharmaceuticals | 75% | |
| PepGen | 72% | |
| Avidity Biosciences | 68% |
pacDNA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 17, 2025 | ||||
| Grant | Sep 1, 2023 | ||||
| Grant | Dec 1, 2022 | ||||
| Accelerator | Sep 1, 2022 | ||||
| Grant | Jul 1, 2022 |
pacDNA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Congressionally Directed Medical Research Programs | Grant |
| Northeastern University Center for Research Innovation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 17, 2025
$490K grant from Congressionally Directed Medical Research Programs
- Sep 1, 2023
$50K grant received from Northeastern University Center for Research Innovation.
pacDNA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about pacDNA's valuation, stock price, and market status.
Is pacDNA a public or private company?
pacDNA is a private company.
What is the current stock price of pacDNA?
pacDNA is a private company with no public stock price. No recent secondary market data is available.
How much is pacDNA worth (valuation)?
Valuation information for pacDNA is not publicly available.
Can I buy pacDNA stock?
pacDNA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was pacDNA's last funding round?
pacDNA's most recent funding round was Grant on January 17, 2025.
Who are the main investors in pacDNA?
Key investors in pacDNA include NIH RADx, Congressionally Directed Medical Research Programs, Northeastern University Center for Research Innovation.
Will pacDNA IPO soon?
No public IPO plans have been announced for pacDNA.
How can I track pacDNA secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor pacDNA's secondary market activity and sign up for updates.